Revolution Medicines (RVMDW) Competitors $0.27 +0.02 (+7.96%) As of 10:03 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock RVMDW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROWShould you be buying Revolution Medicines stock or one of its competitors? The main competitors of Revolution Medicines include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry. Revolution Medicines vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and Revolution Medicines (NASDAQ:RVMDW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends. Does the media prefer ATNFW or RVMDW? In the previous week, Revolution Medicines had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Revolution Medicines and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.87 beat Revolution Medicines' score of 0.28 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Very Positive Revolution Medicines Neutral Which has better valuation & earnings, ATNFW or RVMDW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ARevolution MedicinesN/AN/AN/AN/AN/A Is ATNFW or RVMDW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Revolution Medicines N/A N/A N/A Summary180 Life Sciences and Revolution Medicines tied by winning 1 of the 2 factors compared between the two stocks. Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMDW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RVMDW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVMDW vs. The Competition Export to ExcelMetricRevolution MedicinesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$130.16M$5.53B$9.06BDividend YieldN/A3.74%5.06%4.03%P/E RatioN/A3.4928.2020.35Price / SalesN/A4,213.56378.0980.87Price / CashN/A13.1926.2427.98Price / BookN/A44.028.255.54Net IncomeN/A-$92.15M$3.18B$250.38M7 Day Performance19.96%1.08%5.51%2.93%1 Month Performance19.96%6.86%9.78%11.77%1 Year Performance42.05%168.51%30.10%17.03% Revolution Medicines Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVMDWRevolution MedicinesN/A$0.27+8.0%N/A+31.6%$0.00N/A0.00378Gap UpATNFW180 Life SciencesN/A$0.01-1.2%N/A-4.7%$0.00N/A0.007SXTPW60 Degrees PharmaceuticalsN/A$0.06+11.5%N/A-12.8%$0.00$665.45K0.002Gap UpDRTSWAlpha Tau MedicalN/A$0.24-1.7%N/A+17.7%$0.00N/A0.0080Gap DownWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.04+13.6%N/A+82.9%$0.00N/A0.0059BCTXWBriaCell TherapeuticsN/A$0.06-17.1%N/A-54.5%$0.00N/A0.008Gap DownCDIOWCardio DiagnosticsN/A$0.02flatN/AN/A$0.00$19.90K0.007Gap DownCTCXWCarmellN/A$0.03+6.8%N/AN/A$0.00$32.84K0.0014Gap UpCELUWCelularityN/A$0.04-5.2%N/AN/A$0.00$54.22M0.00220Gap DownCEROWCERo TherapeuticsN/A$0.02-13.4%N/A-7.0%$0.00N/A0.008Gap Up Related Companies and Tools Related Companies 180 Life Sciences Competitors 60 Degrees Pharmaceuticals Competitors Alpha Tau Medical Competitors Anew Medical Competitors Apollomics Competitors BriaCell Therapeutics Competitors Cardio Diagnostics Competitors Carmell Competitors Celularity Competitors CERo Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RVMDW) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RVMDW Stock Alerts